Table 3. EC50 of LPS Biosynthesis Inhibition of Clinical Isolates by Compound 17 in the Presence of 100 μM Glucose-6-Phosphate (n = 1).
| strain | resistance mechanism | EC50 of LPS heptosylation by 17 (μM) |
|---|---|---|
| E. coli S1 | ESBL | 21 |
| E. cloacae S2 | AmpC | 18 |
| K. pneumoniae S3 | NDM-1 | 21 |